PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Continente #
NA - Nord America 17.073
AS - Asia 7.507
EU - Europa 6.437
SA - Sud America 1.235
Continente sconosciuto - Info sul continente non disponibili 632
AF - Africa 178
OC - Oceania 17
AN - Antartide 1
Totale 33.080
Nazione #
US - Stati Uniti d'America 16.167
SG - Singapore 2.681
IT - Italia 1.911
CN - Cina 1.647
HK - Hong Kong 984
BR - Brasile 923
VN - Vietnam 899
RU - Federazione Russa 885
DE - Germania 861
CA - Canada 666
SE - Svezia 577
IE - Irlanda 520
UA - Ucraina 332
FR - Francia 318
GB - Regno Unito 306
IN - India 251
BD - Bangladesh 241
AT - Austria 214
FI - Finlandia 117
AR - Argentina 116
JP - Giappone 102
TR - Turchia 102
IQ - Iraq 99
KR - Corea 98
ID - Indonesia 82
NL - Olanda 79
MX - Messico 74
ES - Italia 70
DK - Danimarca 68
ZA - Sudafrica 60
CO - Colombia 52
SA - Arabia Saudita 49
PK - Pakistan 47
VE - Venezuela 40
EC - Ecuador 35
UZ - Uzbekistan 35
PL - Polonia 34
CR - Costa Rica 33
JM - Giamaica 30
EG - Egitto 21
PY - Paraguay 21
CL - Cile 20
MY - Malesia 20
PH - Filippine 20
CH - Svizzera 19
MA - Marocco 17
NP - Nepal 17
SV - El Salvador 17
ET - Etiopia 16
IL - Israele 16
BE - Belgio 15
DZ - Algeria 15
GR - Grecia 15
GT - Guatemala 15
PE - Perù 14
PT - Portogallo 14
HN - Honduras 13
LT - Lituania 13
PS - Palestinian Territory 13
TT - Trinidad e Tobago 13
AU - Australia 12
OM - Oman 12
TH - Thailandia 12
AE - Emirati Arabi Uniti 11
TN - Tunisia 11
NI - Nicaragua 10
PA - Panama 10
KE - Kenya 9
PR - Porto Rico 9
UY - Uruguay 9
CW - ???statistics.table.value.countryCode.CW??? 8
IR - Iran 8
RO - Romania 8
SC - Seychelles 8
AL - Albania 7
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LB - Libano 7
NO - Norvegia 7
DO - Repubblica Dominicana 6
JO - Giordania 6
RS - Serbia 6
AZ - Azerbaigian 5
EU - Europa 5
GP - Guadalupe 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
BO - Bolivia 4
CY - Cipro 4
LV - Lettonia 4
TW - Taiwan 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
EE - Estonia 3
HR - Croazia 3
MD - Moldavia 3
Totale 32.411
Città #
Ann Arbor 2.328
Ashburn 1.818
Singapore 1.629
Hong Kong 963
San Jose 853
Woodbridge 672
Fairfield 671
Dallas 564
Chandler 562
Frankfurt am Main 506
Dublin 502
Houston 501
Council Bluffs 479
Wilmington 475
Milan 454
Toronto 390
New York 364
Seattle 312
Jacksonville 307
Santa Clara 301
Beijing 277
Ho Chi Minh City 276
Dearborn 263
Los Angeles 234
Chicago 229
Cambridge 222
Phoenix 208
Princeton 196
The Dalles 194
Vienna 193
Hefei 184
Hanoi 177
Rome 146
Nanjing 143
Lauterbourg 113
São Paulo 102
Altamura 92
Lawrence 92
Seoul 90
Buffalo 87
Moscow 77
Boardman 75
Shanghai 72
Columbus 64
San Diego 59
Tokyo 59
Orem 53
Montreal 52
Guangzhou 51
Jakarta 50
Dong Ket 48
Brooklyn 47
Atlanta 46
London 44
Lachine 43
Nanchang 43
Baghdad 39
Helsinki 39
Da Nang 38
Falls Church 38
Washington 37
Haiphong 36
San Francisco 34
Denver 33
Munich 33
Lissone 32
Nuremberg 32
Pune 32
Shenyang 32
Tashkent 32
Andover 31
Jinan 31
Turin 30
Naples 29
North Bergen 29
Tianjin 29
Changsha 27
Ottawa 27
Salt Lake City 27
Boston 25
Dhaka 25
San José 25
Tampa 25
Warsaw 25
Zhengzhou 25
Figino 23
Jeddah 23
Johannesburg 23
Philadelphia 23
Belo Horizonte 21
Florence 21
Miami 21
Rio de Janeiro 21
Bologna 20
Chennai 20
Hebei 20
Manchester 20
New Delhi 20
Kingston 19
Mumbai 19
Totale 20.263
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 751
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 556
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 554
Microscopic Polyangiitis 480
The putative role of MALDI-MSI in the study of Membranous Nephropathy 471
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 433
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 426
MALDI imaging in Fabry nephropathy: a multicenter study 426
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 425
Kidney Involvement 408
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 407
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 402
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 400
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 395
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 388
Proteomics for the study of new biomarkers in Fabry disease: State of the art 370
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 354
Usefulness of waist circumference for the identification of childhood hypertension 349
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 345
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 343
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 334
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 333
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 330
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 329
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 322
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 318
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 316
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 315
Obesity-associated hypertension in childhood: A new epidemic problem 312
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 305
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 303
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 298
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 298
Protein-Bound Uremic Toxins and Inflammation Process in Hemodialysis Patients: Is There a Role for Adsorption Hemodiafiltration? 297
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 297
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 291
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 283
Sympathetic activation in cardiovascular and renal disease 281
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 278
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 275
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 272
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 271
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 268
Parapelvic cysts, a distinguishing feature of renal Fabry disease 267
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 267
Interpretation of GFR slope in untreated and treated adult Fabry patients 266
Role of fat distribution indicators in the identification of hypertension in children 265
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 263
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 261
Avacopan for the treatment of ANCA-associated vasculitis 259
Anticoagulant-related nephropathy: a pathological note 258
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 257
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 256
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 253
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 252
Tumour incidence in Fabry disease: A cross-sectional study 251
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 250
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 248
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 248
Renal afferents signaling diuretic activity in the cat 248
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 248
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 246
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 245
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 241
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 240
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 239
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 238
ANCA-associated vasculitis in childhood: Recent advances 235
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial 234
La terapia enzimatica sostitutiva nella malattia di Fabry 234
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 234
Redefining the pulvinar sign in fabry disease 228
PICC insertion and veins of the arm size variation during dialysis treatment: A prospective observational study 227
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 227
[Clinical and histological findings in Fabry nephropathy] 227
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 226
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 225
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 224
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 221
Analysis of heart period and arterial pressure variability in childhood hypertension: Key role of baroreflex impairment 220
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 220
La diagnosi precoce di malattia 218
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 216
Hypertension in childhood: autonomic and metabolic patterns 215
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 213
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study 206
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 204
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 203
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 203
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 202
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 202
Cardiovascular magnetic resonance insights into anomalies of the mitral valve apparatus in Fabry cardiomyopathy and hypertrophic cardiomyopathy 199
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 198
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 197
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan 195
Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis 195
Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs 195
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 195
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 194
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 189
Totale 28.696
Categoria #
all - tutte 105.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022926 0 0 0 0 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.660 56 46 53 81 191 506 288 56 119 31 42 191
2024/20254.413 266 395 261 189 345 148 270 133 511 813 402 680
2025/202610.804 1.145 705 1.059 976 1.185 499 1.470 550 840 815 739 821
2026/20274.409 450 570 1.359 1.701 329 0 0 0 0 0 0 0
Totale 33.080